½ÃÀ庸°í¼­
»óǰÄÚµå
1355655

¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ±â¼ú ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Multimodal Imaging Market Size study & Forecast, by Technology Application, End-User, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀåÀº ¿¹Ãø ±â°£ÀÎ 2023-2030³â 5.2% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¸ÖƼ¸ð´Þ À̹Ì¡Àº ŹÝÀÇ ±¸Á¶¿Í ±â´É»Ó¸¸ ¾Æ´Ï¶ó ¹è¾Æ ¹ß»ýÀ» Æ÷ÇÔÇÑ ´Ù¸¥ ÇüÁúÀ» ¿¬±¸ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸´Â Á¾Á¾ ÇüÁúÀüȯ »ýÁ㸦 ÀÌ¿ëÇØ ¼öÇàµË´Ï´Ù. ÅÂ¾Æ¿Í ¸ðü Ç÷°ü°èÀÇ ±â´É°ú ±¸Á¶, ŹÝÀÇ ±¸Á¶¿Í ³»ºÎ ±³È¯Àº ¸ðµÎ »õ·Î °³¹ßµÈ À̹Ì¡ ÅøÀ» »ç¿ëÇÏ¿© °³¼±µÉ ¼ö ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê°ú ÀÇ·áºñ Áõ°¡·Î ÀÎÇÑ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀåÀÇ °ý¸ñÇÒ ¸¸ÇÑ °³Ã´

Statista¿¡ µû¸£¸é 2028-2038³â±îÁö ÀÌÅ»¸®¾Æ¿¡¼­ ¿¹»óµÇ´Â ¸¸¼ºÁúȯÀÚ ¼ö´Â 2,523¸¸ 3,000¸íÀÔ´Ï´Ù. µ¥ÀÌÅÍ¿¡ µû¸£¸é 2028³â±îÁö 2,523¸¸ 3,000¸íÀÌ Àû¾îµµ ÇϳªÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ¹Ý¸é, °°Àº ÇØ¿¡ µÎ °¡Áö ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷Àº 1,397¸¸ 7,000¸íÀ̸ç, 2038³â±îÁö 1,467¸¸ 3,000¸íÀÇ ÀÌÅ»¸®¾ÆÀÎÀÌ µÎ °¡Áö ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°Ô µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°Ô µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¾ÏÇùȸ´Â 2019³â ¹Ì±¹¿¡¼­ ¾à 606,880¸í, Áï ¸ÅÀÏ 1,660¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ±â¼úÀûÀ¸·Î Á¤±³ÇÑ ¿µ»ó Áø´Ü ÀåºñÀÇ ±Þ¼ÓÇÑ º¸±ÞÀ¸·Î ÀÌ Áö¿ª ½ÃÀåÀº ȣȲÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñħ½ÀÀû Áø´Ü ÀýÂ÷ÀÇ »ç¿ë·® Áõ°¡¿Í ÷´Ü ÀÇ·á ÀÎÇÁ¶óÀÇ ÀÌ¿ë °¡´É¼ºÀº ÇâÈÄ ¼ö³â°£ À¯¸®ÇÑ ºñÁî´Ï½º ±âȸ¸¦ âÃâÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ÀûÀýÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ ºÎÁ·°ú ¸ÖƼ¸ð´Þ À̹Ì¡ ½Ã½ºÅÛÀÇ ³ôÀº °¡°ÝÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â °í·ÉÈ­ Àα¸ Áõ°¡¿Í ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ ¼¼°è ½ÃÀå Á¡À¯À²À» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº »õ·Î¿î ¿µ»ó ±â¼ú °ü·Ã °³¹ß Áõ°¡¿Í ÀÇ·á »ê¾÷ÀÇ ºÎ»óÀ¸·Î ÀÎÇØ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå ¿ªÇÐ

  • ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
      • ÀÇ·á ÁöÃâÀÇ Áõ°¡
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • ÀûÀýÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ °á¿©
      • ¸ÖƼ¸ð´Þ À̹Ì¡ ½Ã½ºÅÛÀÇ °í°¡°Ý
    • ½ÃÀå ±âȸ
      • ºñħ½ÀÀû Áø´Ü ½Ã¼ú¿¡¼­ »ç¿ëÀÇ Áõ°¡
      • ÷´Ü ÀÇ·á ÀÎÇÁ¶óÀÇ ÀÌ¿ë °¡´É¼º

Á¦4Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð¡¤Á¦¾È

Á¦5Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ±â¼úº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ±â¼úº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ±â¼úº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • PET/CT ½Ã½ºÅÛ
    • SPECT/CT ½Ã½ºÅÛ
    • PET/MR ½Ã½ºÅÛ
    • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ¿ëµµº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Á¾¾çÇÐ
    • ¾È°ú
    • ¼øÈ¯±â
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • Áø´Ü ¼¾ÅÍ
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼ô
  • ºÏ¹Ì
    • ¹Ì±¹
      • ±â¼ú, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿ëµµº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾»ç¿ëÀÚ, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå ½º³À¼ô
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå ½º³À¼ô
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÖƼ¸ð´Þ À̹Ì¡ ½ÃÀå ½º³À¼ô
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Topcon Corporation
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ °¡¿ë¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Siemens Healthineers
    • Neusoft Medical Systems Co. Ltd.
    • United Imaging Healthcare Co. Ltd.
    • Infraredx Inc.
    • Koninklijke Philips N.V.
    • Canon Inc.
    • Mediso Medical Imaging Systems Kft
    • GE Healthcare
    • Spectrum Dynamics Medical

Á¦10Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ±¤¾÷
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç ÀüÁ¦Á¶°Ç
KSA 23.10.27

Global Multimodal Imaging Market is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2023-2030. Multimodal imaging is used to research the structure and functioning of the placenta as well as other traits including embryo development. These studies are often carried out in transgenic mice. The function and architecture of the foetal and maternal vascular systems, as well as the structure and internal exchanges of the placenta, may all be improved with the use of newly developed imaging tools. Significant development in Multimodal Imaging market due to growing Prevalence of Chronic Illness and rise in the healthcare expenditure.

According to Statista, the projected number of chronic illness patients in Italy between 2028 and 2038. Data indicate that 25,233 thousand people might have at least one chronic ailment by 2028, compared to 13,907 thousand people who could have at least two chronic illnesses in the same year. By 2038, 14,673 thousand Italians are expected to be concerned about two or more chronic illnesses. Furthermore, The American Cancer Society predicts that in 2019, there will be around 606,880 cancer-related deaths in the United States, or 1,660 each day. The market is booming in the area as a result of the rising prevalence of chronic illnesses and the quick uptake of technologically sophisticated imaging devices. Moreover, increasing usage in the non-invasive diagnostic procedures and availability of advanced healthcare infrastructure create lucrative opportunities in the upcoming years. However, lack of appropriate healthcare infrastructure and high price of the multimodal imaging system stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Multimodal Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increase in the aging population, rise in the healthcare expenditure. However, Asia Pacific is expected to be the fastest growing region due to rising development related to new imaging technique and rising healthcare industry.

Major market player included in this report are:

  • Topcon Corporation
  • Siemens Healthineers
  • Neusoft Medical Systems Co. Ltd.
  • United Imaging Healthcare Co. Ltd.
  • Infraredx Inc.
  • Koninklijke Philips N.V.
  • Canon Inc.
  • Mediso Medical Imaging Systems Kft
  • GE Healthcare
  • Spectrum Dynamics Medical

Recent Developments in the Market:

  • January 2019, the uEXPLORER complete body PET/CT technology was unveiled by United Imaging Healthcare Co., Ltd. The objective of uEXPLORER is to transform molecular imaging by switching from conventional whole-body PET/CT imaging to simultaneous total-body imaging.

Global Multimodal Imaging Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Application, End-user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

  • PET/CT Systems
  • SPECT/CT Systems
  • PET/MR Systems
  • Others

By Application:

  • Oncology
  • Ophthalmology
  • Cardiology
  • Others

By End-user:

  • Hospitals
  • Diagnostic Centers
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Multimodal Imaging Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Multimodal Imaging Market, by Technology, 2020-2030 (USD Billion)
    • 1.2.3. Multimodal Imaging Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Multimodal Imaging Market, by End-user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Multimodal Imaging Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Multimodal Imaging Market Dynamics

  • 3.1. Multimodal Imaging Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing Prevalence of Chronic illnesses
      • 3.1.1.2. Rise in the healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of appropriate healthcare infrastructure
      • 3.1.2.2. High price of the multimodal imaging system
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing usage in the non-invasive diagnostic procedures
      • 3.1.3.2. Availability of advanced healthcare infrastructure

Chapter 4. Global Multimodal Imaging Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Multimodal Imaging Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Global Multimodal Imaging Market by Technology, Performance - Potential Analysis
  • 5.3. Global Multimodal Imaging Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 5.4. Multimodal Imaging Market, Sub Segment Analysis
    • 5.4.1. PET/CT Systems
    • 5.4.2. SPECT/CT Systems
    • 5.4.3. PET/MR Systems
    • 5.4.4. Others

Chapter 6. Global Multimodal Imaging Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Multimodal Imaging Market by Application, Performance - Potential Analysis
  • 6.3. Global Multimodal Imaging Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Multimodal Imaging Market, Sub Segment Analysis
    • 6.4.1. Oncology
    • 6.4.2. Ophthalmology
    • 6.4.3. Cardiology
    • 6.4.4. Others

Chapter 7. Global Multimodal Imaging Market, by End-user

  • 7.1. Market Snapshot
  • 7.2. Global Multimodal Imaging Market by End-user, Performance - Potential Analysis
  • 7.3. Global Multimodal Imaging Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 7.4. Multimodal Imaging Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Centers
    • 7.4.3. Others

Chapter 8. Global Multimodal Imaging Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Multimodal Imaging Market, Regional Market Snapshot
  • 8.4. North America Multimodal Imaging Market
    • 8.4.1. U.S. Multimodal Imaging Market
      • 8.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Multimodal Imaging Market
  • 8.5. Europe Multimodal Imaging Market Snapshot
    • 8.5.1. U.K. Multimodal Imaging Market
    • 8.5.2. Germany Multimodal Imaging Market
    • 8.5.3. France Multimodal Imaging Market
    • 8.5.4. Spain Multimodal Imaging Market
    • 8.5.5. Italy Multimodal Imaging Market
    • 8.5.6. Rest of Europe Multimodal Imaging Market
  • 8.6. Asia-Pacific Multimodal Imaging Market Snapshot
    • 8.6.1. China Multimodal Imaging Market
    • 8.6.2. India Multimodal Imaging Market
    • 8.6.3. Japan Multimodal Imaging Market
    • 8.6.4. Australia Multimodal Imaging Market
    • 8.6.5. South Korea Multimodal Imaging Market
    • 8.6.6. Rest of Asia Pacific Multimodal Imaging Market
  • 8.7. Latin America Multimodal Imaging Market Snapshot
    • 8.7.1. Brazil Multimodal Imaging Market
    • 8.7.2. Mexico Multimodal Imaging Market
  • 8.8. Middle East & Africa Multimodal Imaging Market
    • 8.8.1. Saudi Arabia Multimodal Imaging Market
    • 8.8.2. South Africa Multimodal Imaging Market
    • 8.8.3. Rest of Middle East & Africa Multimodal Imaging Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Topcon Corporation
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Siemens Healthineers
    • 9.3.3. Neusoft Medical Systems Co. Ltd.
    • 9.3.4. United Imaging Healthcare Co. Ltd.
    • 9.3.5. Infraredx Inc.
    • 9.3.6. Koninklijke Philips N.V.
    • 9.3.7. Canon Inc.
    • 9.3.8. Mediso Medical Imaging Systems Kft
    • 9.3.9. GE Healthcare
    • 9.3.10. Spectrum Dynamics Medical

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦